These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16533529

  • 1. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
    Lorenzo F, Nishii K, Monma F, Kuwagata S, Usui E, Shiku H.
    Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
    [Abstract] [Full Text] [Related]

  • 2. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M, Küpper AC, Tapprich C, Bottomley SS, Bowen D, Germing U, Haas R, Gattermann N.
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
    Yang JK, Li JL, Li ZG, Li ZG, Liu PJ, Li JY, Lü HR, Deng Q, Lin XM, Cao JN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
    [Abstract] [Full Text] [Related]

  • 6. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.
    Kaeferstein A, Krug U, Tiesmeier J, Aivado M, Faulhaber M, Stadler M, Krauter J, Germing U, Hofmann WK, Koeffler HP, Ganser A, Verbeek W.
    Leukemia; 2003 Feb; 17(2):343-9. PubMed ID: 12592334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
    Shao Z, Zhang H, Chen G, Wang L, Li K, Zhang Y, Li L, Sun J.
    Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
    [Abstract] [Full Text] [Related]

  • 9. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
    Georgiou G, Karali V, Zouvelou C, Kyriakou E, Dimou M, Chrisochoou S, Greka P, Dufexis D, Vervesou E, Dimitriadou E, Efthymiou A, Petrikkos L, Dima K, Lilakos K, Panayiotidis P.
    Br J Haematol; 2006 Aug; 134(3):302-6. PubMed ID: 16787503
    [Abstract] [Full Text] [Related]

  • 10. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ.
    Hematol Pathol; 1987 Aug; 1(4):203-8. PubMed ID: 3504436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM, Stass SA, Pierce S, Estey EH.
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [Abstract] [Full Text] [Related]

  • 15. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
    Wu S, Xie G, Bai R, Wang Y, Zhu P.
    Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
    [Abstract] [Full Text] [Related]

  • 16. Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome.
    Badran A, Yoshida A, Wano Y, Mutoh M, Imamura S, Yamashita T, Tsutani H, Inuzuka M, Ueda T.
    Int J Oncol; 2003 Jan; 22(1):59-64. PubMed ID: 12469185
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M, Mirro J, Kitchingman G, McCormick F, Mertelsmann R, Herrmann F, Koeffler HP.
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [Abstract] [Full Text] [Related]

  • 18. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A.
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [Abstract] [Full Text] [Related]

  • 19. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG, Pappa V, Papageorgiou E, Tsirigotis P, Kontsioti F, Panani A, Dervenoulas J, Economopoulos T.
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [Abstract] [Full Text] [Related]

  • 20. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
    Shikama Y, Shichishima T, Ohto H, Jubinsky PT, Maruyama Y.
    Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.